Diffusion of Technologies for the Care of Older Adults With Exudative Age-Related Macular Degeneration

Newer, more effective therapeutic interventions for exudative AMD diffused rapidly throughout the United States, quickly replacing older, less effective interventions. Although improving patient outcomes, rapid diffusion raises important public policy issues for Medicare and other payers to consider.